5/13
09:44 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
5/13
09:44 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
5/10
10:52 am
syre
Rating for SYRE
Medium
Report
Rating for SYRE
5/2
07:08 am
syre
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $50.00 price target on the stock.
5/2
05:05 am
syre
Rating for SYRE
Medium
Report
Rating for SYRE
5/2
05:05 am
syre
Rating for SYRE
Medium
Report
Rating for SYRE